Tekla Financial Statements From 2010 to 2025
| HQL Stock | USD 13.67 0.31 2.32% |
Check Tekla Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tekla financial statements analysis is a perfect complement when working with Tekla Life Valuation or Volatility modules.
Check out the analysis of Tekla Life Correlation against competitors. Tekla Life Sciences Company Operating Margin Analysis
Tekla Life's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Tekla Life Operating Margin | (1.01) % |
Most of Tekla Life's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Tekla Life Sciences has an Operating Margin of -1.0099%. This is 105.47% lower than that of the Capital Markets sector and 103.9% lower than that of the Financials industry. The operating margin for all United States stocks is 81.67% lower than that of the firm.
Tekla Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Life's current stock value. Our valuation model uses many indicators to compare Tekla Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla Life competition to find correlations between indicators driving Tekla Life's intrinsic value. More Info.Tekla Life Sciences is rated # 2 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Tekla Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Tekla Life Financial Statements
Tekla Life investors utilize fundamental indicators, such as revenue or net income, to predict how Tekla Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Tekla Life Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.